West Pharmaceutical Services, Inc. (NYSE:WST) Shares Purchased by Whittier Trust Co.

Whittier Trust Co. lifted its position in West Pharmaceutical Services, Inc. (NYSE:WST) by 4.4% during the 3rd quarter, Holdings Channel.com reports. The fund owned 41,804 shares of the medical instruments supplier’s stock after acquiring an additional 1,779 shares during the period. Whittier Trust Co.’s holdings in West Pharmaceutical Services were worth $12,547,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently made changes to their positions in the company. Pitcairn Co. increased its position in shares of West Pharmaceutical Services by 3.4% in the 1st quarter. Pitcairn Co. now owns 875 shares of the medical instruments supplier’s stock valued at $346,000 after acquiring an additional 29 shares during the period. Clearbridge Investments LLC increased its position in shares of West Pharmaceutical Services by 0.7% in the 1st quarter. Clearbridge Investments LLC now owns 4,495 shares of the medical instruments supplier’s stock valued at $1,779,000 after acquiring an additional 31 shares during the period. RFG Advisory LLC increased its position in shares of West Pharmaceutical Services by 2.3% in the 1st quarter. RFG Advisory LLC now owns 1,465 shares of the medical instruments supplier’s stock valued at $580,000 after acquiring an additional 33 shares during the period. Ballentine Partners LLC increased its position in shares of West Pharmaceutical Services by 4.7% in the 2nd quarter. Ballentine Partners LLC now owns 742 shares of the medical instruments supplier’s stock valued at $244,000 after acquiring an additional 33 shares during the period. Finally, Wallace Advisory Group LLC increased its position in shares of West Pharmaceutical Services by 4.5% in the 1st quarter. Wallace Advisory Group LLC now owns 957 shares of the medical instruments supplier’s stock valued at $379,000 after acquiring an additional 41 shares during the period. 93.90% of the stock is owned by institutional investors and hedge funds.

West Pharmaceutical Services Stock Performance

WST traded down $4.55 during midday trading on Monday, hitting $288.77. 140,527 shares of the company were exchanged, compared to its average volume of 549,860. The company’s 50 day simple moving average is $299.96 and its 200 day simple moving average is $324.95. The firm has a market capitalization of $20.95 billion, a price-to-earnings ratio of 41.72, a price-to-earnings-growth ratio of 10.46 and a beta of 1.01. The company has a current ratio of 2.34, a quick ratio of 1.68 and a debt-to-equity ratio of 0.03. West Pharmaceutical Services, Inc. has a 1-year low of $265.00 and a 1-year high of $413.70.

West Pharmaceutical Services (NYSE:WST) last announced its quarterly earnings results on Thursday, July 25th. The medical instruments supplier reported $1.52 earnings per share for the quarter, missing the consensus estimate of $1.74 by ($0.22). West Pharmaceutical Services had a return on equity of 19.17% and a net margin of 18.25%. The company had revenue of $702.10 million for the quarter, compared to analyst estimates of $729.36 million. During the same period in the prior year, the business posted $2.11 earnings per share. West Pharmaceutical Services’s revenue for the quarter was down 6.9% on a year-over-year basis. As a group, sell-side analysts predict that West Pharmaceutical Services, Inc. will post 6.42 earnings per share for the current year.

Insider Transactions at West Pharmaceutical Services

In related news, VP Charles Witherspoon sold 1,029 shares of the firm’s stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $300.00, for a total value of $308,700.00. Following the transaction, the vice president now directly owns 1,478 shares of the company’s stock, valued at approximately $443,400. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.53% of the company’s stock.

West Pharmaceutical Services Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.